TMCnet News
Global Psychiatry Partnering Directory 2018 - ResearchAndMarkets.comThe "Global Psychiatry Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Psychiatry Partnering 2012 to 2018 provides the full collection of Psychiatry disease deals signed between the world's pharmaceutical and biotechnology companies since 2012. Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive Psychiatry disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Psychiatry deals.
In addition, a comprehensive appendix is provided with each report of all Psychiatry partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Psychiatry technologies and products. Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in Psychiatry dealmaking Chapter 3 - Financial deal terms for Psychiatry partnering Chapter 4 - Leading Psychiatry deals and dealmakers Chapter 5 - Psychiatry contract document directory Chapter 6 - Psychiatry dealmaking by therapeutic target For more information about this report visit https://www.researchandmarkets.com/research/8qlb5q/global_psychiatry?w=4 View source version on businesswire.com: https://www.businesswire.com/news/home/20180321005529/en/ |
